Skip to main content

40 Hz Masked Light: A new venture to slow the progression of Alzheimer’s Disease

Project description

Slowing down Alzheimer's disease with flashing light

Available treatments for Alzheimer's disease (AD) are ineffective and fail to halt progressive and irreversible brain damage. Recent evidence indicates that non-invasive flashing light can clear amyloid-beta, one of the key pathogenic hallmarks of AD, and offer neural protection. The EU-funded BRIGHT project will conduct a feasibility study for a novel flickering white light therapy that can stimulate the human visual receptors and processing cortex. The white light forms by combining different coloured LEDs and does not cause fatigue like stroboscopic light. The proposed intervention has the potential to delay disease onset, reduce prevalence and associated costs.

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Coordinator

OPTOCEUTICS APS
Address
Diplomvej 381
2800 Kongens Lyngby
Denmark
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000